Sirios Capital Management L P Catalent, Inc. Transaction History

Sirios Capital Management L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$47.45 - $58.05 $290,204 - $355,033	-6,116 Reduced 21.29%	22,612 $1.08 Million
Q2 2019 Aug 14, 2019	SELL	$39.26 - $54.21 $599,892 - $828,328	-15,280 Reduced 34.72%	28,728 $1.56 Million
Q1 2019 May 15, 2019	SELL	$29.84 - $43.92 $96,651 - $142,256	-3,239 Reduced 6.86%	44,008 $1.79 Million
Q4 2018 Feb 14, 2019	BUY	$29.95 - $46.34 $1.42 Million - $2.19 Million	47,247 New	47,247 $1.47 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Sirios Capital Management L P, based on Form 13F filings with the SEC.

Stay updated on Sirios Capital Management L P with notifications on news.